← Back to Discover
Exome Asset Management LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $162,102,170
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- GUARDANT HEALTH INC · COM · 40131M109 · shares: $10,127,025
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $9,107,962
- TG THERAPEUTICS INC · COM · 88322Q108 · shares: $9,060,430
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $8,147,240
- IONIS PHARMACEUTICALS INC · COM · 462222100 · shares: $6,991,554
- ELI LILLY & CO · COM · 532457108 · shares: $6,587,270
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $6,246,962
- ALUMIS INC · COM · 022307102 · shares: $5,752,323
- CYTOKINETICS INC · COM NEW · 23282W605 · shares: $5,116,171
- ENLIVEN THERAPEUTICS INC · COM · 29337E102 · shares: $5,085,302
Reported holdings
52 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| GUARDANT HEALTH INC | COM | 40131M109 | — | 67,500 shares | $10,127,025 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 27,205 shares | $9,107,962 |
| TG THERAPEUTICS INC | COM | 88322Q108 | — | 164,915 shares | $9,060,430 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 210,523 shares | $8,147,240 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 88,177 shares | $6,991,554 |
| ELI LILLY & CO | COM | 532457108 | — | 5,492 shares | $6,587,270 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 46,878 shares | $6,246,962 |
| ALUMIS INC | COM | 022307102 | — | 204,418 shares | $5,752,323 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 60,056 shares | $5,116,171 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 100,203 shares | $5,085,302 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 97,276 shares | $4,174,113 |
| UNITEDHEALTH GROUP INC | COM | 91324P102 | — | 9,612 shares | $3,995,036 |
| 10X GENOMICS INC | CL A COM | 88025U109 | — | 102,629 shares | $3,934,796 |
| NATERA INC | COM | 632307104 | — | 13,800 shares | $3,746,010 |
| UNIQURE NV | SHS | N90064101 | — | 81,056 shares | $3,733,439 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 32,209 shares | $3,576,165 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 114,692 shares | $3,422,409 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 137,115 shares | $3,318,183 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 166,493 shares | $3,241,619 |
| ALKERMES PLC | SHS | G01767105 | — | 61,336 shares | $3,213,700 |
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | — | 39,224 shares | $3,127,330 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 5,410 shares | $2,931,300 |
| GLAUKOS CORP | COM | 377322102 | — | 19,862 shares | $2,775,913 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 32,214 shares | $2,625,763 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 70,500 shares | $2,616,255 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 127,769 shares | $2,299,842 |
| ASTRAZENECA PLC | ORD | G0593M107 | — | 12,045 shares | $2,254,128 |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | — | 48,347 shares | $2,063,450 |
| ADAGENE INC | ADS | 005329107 | — | 488,293 shares | $2,050,831 |
| PENUMBRA INC | COM | 70975L107 | — | 6,300 shares | $1,989,225 |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | — | 4,908 shares | $1,951,813 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 47,861 shares | $1,867,058 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 181,588 shares | $1,783,194 |
| EQUILLIUM INC | COM | 29446K106 | — | 552,956 shares | $1,769,459 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 6,573 shares | $1,753,151 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 184,914 shares | $1,734,493 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 460,067 shares | $1,725,251 |
| VERASTEM INC | COM NEW | 92337C203 | — | 429,041 shares | $1,638,937 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 22,417 shares | $1,564,931 |
| CLEARPOINT NEURO INC | COM | 18507C103 | — | 83,636 shares | $1,492,066 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 13,873 shares | $1,479,139 |
| CARIS LIFE SCIENCES INC | COM | 142152107 | — | 78,180 shares | $1,393,168 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 18,359 shares | $1,367,378 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 52,443 shares | $1,331,003 |
| NOVABRIDGE BIOSCIENCES | SPONSORED ADS | 44975P103 | — | 576,960 shares | $1,125,072 |
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | — | 13,100 shares | $1,124,111 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 47,531 shares | $889,305 |
| GERON CORP | COM | 374163103 | — | 624,046 shares | $798,779 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 10,110 shares | $709,722 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 276,165 shares | $604,801 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 40,361 shares | $446,796 |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | — | 50,166 shares | $240,797 |